Clinical Trials Directory

Trials / Unknown

UnknownNCT04604535

The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy

The Effects of Dietary Nitrate Supplementation on Pregnancies Complicated by Chronic and New Onset Hypertension

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
King's College Hospital NHS Trust · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a randomised placebo controlled trial investigating the effects of dietary nitrate supplementation on hypertension in pregnancy

Detailed description

Reduced nitrate and nitrite concentrations have been found in women with preeclampsia (PE) and studies have shown increased concentrations of an endogenously generated Nitric Oxide Synthase inhibitor, amongst women with PE. Nitrate and nitrite are required to produce Nitric Oxide (NO). NO is released from the endothelial lining of blood vessels, and acts to relax smooth muscle within the vasculature, acting as a potent vasodilator. Reduced NO concentrations are hence thought to contribute towards the systemic vascular constriction seen in PE. Hypertensive diseases in pregnancy are an important cause of morbidity and mortality in both maternal, fetal and neonatal health. Treatment options are limited in pregnancy and hence alternative methods to improve blood pressure control should be sought. In this randomised placebo controlled double blinded trial we aim to assess the effect of dietary nitrate supplementation on the hypertensive diseases of pregnancy and the subsequent maternal, fetal-neonatal outcomes. The safety and acceptability of dietary nitrate supplementation will also be confirmed in this study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTConcentrated beetroot juice70mL concentrated beetroot juice (400mg nitrate)
DIETARY_SUPPLEMENTPlacebo70mL concentrated nitrate deplete beetroot juice (\<0.01mmol/L nitrate)

Timeline

Start date
2020-10-22
Primary completion
2022-06-30
Completion
2022-12-30
First posted
2020-10-27
Last updated
2020-10-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04604535. Inclusion in this directory is not an endorsement.